 David Kyne |
Evoke, healthcare, medical marketing and communications unit of Huntsworth, has acquired independent health PR specialist KYNE, the ten-year-old shop that registered $10.4M in fees on O'Dwyer's 2018 rankings of healthcare firms.
KYNE and Evoke's PR & Influence unit, which offers strategic communications, PA, investor relations and consumer marketing services, will join to form a new entity
David Kyne will head Evoke KYNE, reporting to Evoke CEO Reid Connolly.
Evoke PR & Influence president Maryellen Royle, KYNE EVP, GM Maureen Byrne and KYNE EVP Wendy Woods-Williams will serve as partners at Evoke KYNE.
“This acquisition is a wonderful event for both our clients and our teams,” Royle told O’Dwyer’s. “Our healthcare client base, in both the private and public sectors, will gain access to new talent, thinking and resources across a much broader geographic reach. And for our internal team, it offers fresh opportunities for them to leverage their unique communications expertise across a more diverse portfolio.”
Evoke reported $12M in PR fees on O'Dwyer's healthcare rankings list.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
